Surviving Alzheimer’s Podcast:
Clarity, Courage, and Care
- 
      
        
  
  
  
  
  
• 10/29/25Clinical Trials Demystified: 6 Years as an Alzheimer's Study Partner | Surviving Alzheimer's Podcast
After 6 years as my mother's study partner in the Leqembi clinical trial, I'm pulling back the curtain on what really happens in Alzheimer's research. This isn't theory—this is lived experience.
In This Episode: ⏱️ 0:00 - Introduction: Why clinical trials feel mysterious ⏱️ 3:45 - How Alzheimer's trials actually work ⏱️ 12:20 - The truth about placebos ⏱️ 18:15 - Who qualifies for trials & why ⏱️ 24:30 - The study partner role that healed my helplessness ⏱️ 31:10 - Safety protocols that build trust ⏱️ 37:45 - Myths we need to bust ⏱️ 43:20 - How to find trials + questions to ask ⏱️ 49:00 - From trial to treatment: Mom's drug is now FDA-approved
Resources Mentioned:
Alzheimer's Association TrialMatch
Memory Treatment Advisors discovery calls: memorytreatmentadvisors.com/schedule
The drug my mom tested (BAN2401) is now FDA-approved Leqembi—proof that trial participation creates real-world impact for families nationwide.
Whether you're considering a trial or simply want to understand your options, this episode provides the clarity you deserve.After 6 years as my mother's study partner in the Leqembi clinical trial, I'm pulling back the curtain on what really happens in Alzheimer's research. This isn't theory—this is lived experience.
Resources Mentioned:
Alzheimer's Association TrialMatch
Memory Treatment Advisors discovery calls: memorytreatmentadvisors.com/schedule
The drug my mom tested (BAN2401) is now FDA-approved Leqembi—proof that trial participation creates real-world impact for families nationwide.
Whether you're considering a trial or simply want to understand your options, this episode provides the clarity you deserve.
 - 
      
        
  
  
  
  
  
• 10/23/25New Oral Alzheimer's Drugs: Who Qualifies and What to Expect
Oral Alzheimer's medications could revolutionize treatment access for millions of families. In this episode, Alzheimer's educator and caregiver Teri Youngdale breaks down everything you need to know about the new oral anti-amyloid drugs in development—who might qualify, how they compare to infusions like Leqembi and Kisunla, and what to expect if these pills become available.
🎙️ What You'll Learn:
How oral Alzheimer's medications work to clear amyloid plaques
Key differences between pills and IV infusion treatments
Who qualifies for oral anti-amyloid therapy
Potential benefits: convenience, cost savings, and greater access
Monitoring requirements and ARIA risks explained
Real stories from families navigating treatment decisions
Timeline for FDA approval and availability
📌 Perfect for: Alzheimer's caregivers, families exploring treatment options, those living far from infusion centers, people with MCI or early-stage Alzheimer's, healthcare advocates, and anyone seeking the latest Alzheimer's research updates.
 
🔗 RESOURCES:
📅 Book Your Free 10-Minute Clarity Call: https://www.memorytreatmentadvisors.com/schedule
📰 Weekly Blog (Tuesdays at 9AM): https://www.alzheimersurvivor.com
🎧 Subscribe to Surviving Alzheimer's Podcast: New episodes every Thursday at 9AM
💬 NEXT WEEK: Clinical Trials Demystified - Learn how clinical trials work, who qualifies, and whether trial participation might be right for your family. Don't miss it!
ABOUT TERI YOUNGDALE: Teri is an Alzheimer's educator, speaker, author, and founder of Memory Treatment Advisors and Alzheimer's Survivor. As her mother's study partner during the Leqembi clinical trial since 2019, Teri brings firsthand experience navigating cutting-edge Alzheimer's treatments. Her mission: provide clarity, courage, and care for those facing Alzheimer's Disease
CONNECT WITH TERI: 🌐 Website: https://www.alzheimersurvivor.com 🌐 Memory Treatment Advisors: https://www.memorytreatmentadvisors.com 📧 Alzheimer's Treatment Care Circle: Every Thursday night & Saturday afternoon on Zoom
#AlzheimersAwareness #OralMedications #LeqembiTreatment #AlzheimersCaregivers #DiseaseModifyingTherapy #AlzheimersResearch #ClinicalTrials #MemoryTreatmentAdvisors #AlzheimersSurvivor #DementiaSupport #CaregiverSupport #AlzheimersEducation #AntiAmyloidTherapy #ARIA #AlzheimersPill #NewTreatmentOptions #AlzheimersHope #MCITreatment #EarlyAlzheimers #AlzheimersAdvocacy
⚠️ DISCLAIMER: This podcast is for educational purposes only and does not constitute medical advice. Always consult with qualified healthcare professionals before making treatment decisions.
👍 If this episode helped you, please
Like this video
Subscribe for weekly episodes
Share with families navigating Alzheimer's
Leave a comment with your questions or experiences
Join our Alzheimer's Treatment Care Circle community
Your engagement helps more families find this life-changing information. Thank you for being part of this community